logo

CUE

Cue Biopharma·NASDAQ
--
--(--)
--
--(--)

CUE fundamentals

Cue Biopharma (CUE) released its earnings on Aug 12, 2025: revenue was 2.95M (YoY +11.14%), beat estimates; EPS was -0.09 (YoY +55.00%), beat estimates.
Revenue / YoY
2.95M
+11.14%
EPS / YoY
-0.09
+55.00%
Report date
Aug 12, 2025
Earnings Call
4:30 PM on Aug 18, 2025
Meeting link.
EPS
Q1,undefined
Q1,2020
Q3,2021
Q4,2021
Q1,2022
Q2,2022
Q3,2022
Q4,2022
Q1,2023
Q2,2023
Q4,2023
Q1,2024
Q2,2024
Q3,2024
Q4,2024
Q1,2025
Q2,2025
Actual
-0.48-0.41-0.26-0.44-0.37-0.31-0.37-0.29-0.29-0.28-0.25-0.2-0.17-0.13-0.17-0.09
Forecast
-0.334-0.385-0.422-0.4025-0.39-0.3767-0.295-0.2775-0.305-0.3-0.282-0.28-0.1825-0.086-0.1533-0.13
Surprise
0.00%
-43.71%
-6.49%
+38.39%
-9.32%
+5.13%
+17.71%
-25.42%
-4.50%
+4.92%
+6.67%
+11.35%
+28.57%
+6.85%
-51.16%
-10.89%
+30.77%
Revenue
Q1,undefined
Q1,2020
Q3,2021
Q4,2021
Q1,2022
Q2,2022
Q3,2022
Q4,2022
Q1,2023
Q2,2023
Q4,2023
Q1,2024
Q2,2024
Q3,2024
Q4,2024
Q1,2025
Q2,2025
Actual
--900.00K2.40M8.25M1.00M26.00K68.00K151.00K187.00K1.38M1.82M1.72M2.66M3.34M1.58M421.00K2.95M
Forecast
--1.36M2.40M1.14M3.05M1.13M513.50K103.75K1.95M907.50K966.67K1.21M1.29M1.52M1.70M1.27M2.00M
Surprise
0.00%
-33.73%
0.00%
+624.67%
-67.26%
-97.70%
-86.76%
+45.54%
-90.41%
+52.29%
+88.38%
+41.83%
+106.21%
+119.55%
-7.36%
-66.79%
+47.70%

Earnings Call